| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 144.969 | 129.017 | - | 127.197 | 187.903 | 113.310 | 152.381 | 205.412 | 172.268 | 171.016 |
| Total Income - EUR | 162.894 | 144.559 | - | 132.105 | 237.926 | 116.275 | 155.232 | 207.413 | 176.714 | 191.996 |
| Total Expenses - EUR | 160.600 | 136.186 | - | 123.137 | 229.822 | 91.764 | 141.616 | 176.274 | 160.710 | 173.893 |
| Gross Profit/Loss - EUR | 2.294 | 8.373 | - | 8.968 | 8.104 | 24.511 | 13.616 | 31.139 | 16.004 | 18.103 |
| Net Profit/Loss - EUR | 1.927 | 7.033 | - | 7.695 | 5.725 | 23.827 | 12.095 | 30.032 | 14.502 | 13.207 |
| Employees | 0 | 0 | - | 8 | 8 | 5 | 5 | 5 | 5 | 4 |
Check the financial reports for the company - Bioexplomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 91.204 | 69.832 | - | 24.880 | 84.864 | 71.444 | 32.855 | 42.901 | 27.343 | 22.617 |
| Current Assets | 54.196 | 69.796 | - | 126.626 | 143.349 | 178.796 | 166.696 | 177.373 | 96.663 | 142.724 |
| Inventories | 877 | 868 | - | 64.797 | 23.709 | 76.238 | 82.319 | 85.973 | 2.748 | 53.462 |
| Receivables | 46.119 | 51.863 | - | 57.368 | 113.869 | 92.980 | 62.750 | 88.688 | 90.988 | 83.662 |
| Cash | 7.200 | 17.064 | - | 4.461 | 5.771 | 9.578 | 21.627 | 2.712 | 2.927 | 5.599 |
| Shareholders Funds | 22.382 | 29.187 | - | 17.816 | 23.196 | 45.684 | 33.467 | 63.604 | 87.487 | 110.278 |
| Social Capital | 112 | 111 | - | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 76.450 | 121.699 | - | 133.477 | 207.309 | 198.805 | 157.053 | 147.612 | 127.061 | 160.018 |
| Income in Advance | 54.155 | 38.062 | - | 16.865 | 16.539 | 16.225 | 15.865 | 15.914 | 15.866 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Bioexplomed S.r.l.